Sherry Oquinn

Background

About Sherry Oquinn

Sherry O’Quinn is a pharmacist and market access expert with over 25 years of experience in pharmaceutical reimbursement strategy, public payer negotiations, and health policy. As the Managing Principal and co-founder of MORSE Consulting, she leads the firm’s consulting services, ensuring clients receive high-quality strategic guidance in navigating complex public reimbursement processes and pan-Canadian Pharmaceutical Alliance (pCPA) negotiations. In her role at MORSE Consulting, Sherry provides innovative reimbursement solutions that align with the firm’s mission to bridge the gap between key market access stakeholders, including pharmaceutical manufacturers, government payers, and healthcare decision-makers. Her expertise in public payer decision-making, drug pricing, and formulary management helps clients develop effective strategies to secure market access for new therapies while ensuring healthcare system sustainability. Previously, Sherry spent over a decade with the Ontario Public Drug Plan (OPDP), where she played a pivotal role in developing the pCPA framework and leading early pCPA negotiations. She oversaw key functions such as Ontario Drug Submissions, Pricing & Product Listing Agreements (PLAs), and public reimbursement policy development. With direct involvement in over 250 public payer negotiations (pCPA & Ontario), she developed a deep understanding of payer decision-making and strategic pricing models that influence access to new therapies. Sherry’s background as a pharmacist spans both hospital and retail settings, giving her a unique perspective on how pharmaceutical policy and reimbursement decisions impact patient access to medications. Her transition into consulting over eight years ago allowed her to apply this expertise in a broader capacity, helping industry stakeholders navigate policy landscapes, optimize payer negotiations, and implement sustainable market access strategies. Sherry is widely respected for her integrity, collaborative approach, and ability to engage with diverse stakeholders to develop sustainable access solutions. Her leadership at MORSE continues to drive strategic innovation in pharmaceutical market access, ensuring clients remain well-positioned to navigate Canada’s evolving reimbursement environment.